Key result
The regulator of calcineurin (RCAN) family of proteins is broadly expressed and regulates calcineurin-dependent and independent pathways across multiple physiological systems and pathologies.
RCAN proteins are important regulators of calcineurin and other physiological systems, highlighting their potential as therapeutic targets beyond Down syndrome.
Should not yet change practice; leaves open RCAN targeting in calcineurin-related cardiovascular disease.
/calmodulin-dependent phosphatase, inhibits calcineurin activity, thereby regulating different physiological events via dephosphorylation of important substrates. Novel functions of RCANs have recently emerged, indicating involvement in mitochondria homeostasis, RNA binding, circadian rhythms, obesity, and thermogenesis, some of which are calcineurin-independent. These developments suggest that besides significant contributions to DS pathologies and calcineurin regulation, RCAN is an important participant across physiological systems, suggesting it as a favorable therapeutic target.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2020) conducted a review in Down syndrome and various pathologies. Regulator of Calcineurin (RCAN) was evaluated. The regulator of calcineurin (RCAN) family of proteins is broadly expressed and regulates calcineurin-dependent and independent pathways across multiple physiological systems and pathologies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: